• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱过度活动症的症状严重程度和患者感知:它们之间有何关联?

Symptom severity and patient perceptions in overactive bladder: how are they related?

机构信息

Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan.

出版信息

BJU Int. 2009 Oct;104(7):968-72. doi: 10.1111/j.1464-410X.2009.08498.x. Epub 2009 Mar 10.

DOI:10.1111/j.1464-410X.2009.08498.x
PMID:19338560
Abstract

OBJECTIVE

To assess the relationship between symptom severity and patient perceptions in patients with overactive bladder (OAB), as estimated by OAB Symptom Score (OABSS) and patient-reported outcome measures, respectively.

PATIENTS AND METHODS

Post-hoc analyses were conducted on the existing data from patients with OAB. In addition to the OABSS, patients completed three patient-reported outcome measures, the OAB questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC) and Medical Outcomes Study Short-Form 36 (SF-36). Relationships of the OABSS were assessed through correlations with the OAB-q, PPBC and SF-36; all analyses were exploratory.

RESULTS

In all, 194 participants were analysed; the OABSS correlated relatively closely with the PPBC and OAB-q subscales of health-related quality of life (r = 0.36-0.57). There was a particularly good correlation with the OAB-q symptom bother (r = 0.73). However, the OABSS correlated somewhat less with the SF-36 subscales (r = 0.16-0.27). There were fairly close correlations between the OABSS and the OAB-q items; for daytime frequency with 'frequency of urination during daytime hours' (r = 0.44); night-time frequency with 'night-time urination' (r = 0.44), 'waking up at night because you had to urinate' (r = 0.51) and 'awakening from sleep' (r = 0.44); urgency with 'a sudden urge to urinate with little or no warning' (r = 0.65) and 'an uncontrollable urge to urinate' (r = 0.69), urgency incontinence with 'accidental loss of small amounts of urine' (r = 0.74) and 'urine loss associated with a strong desire to urinate' (r = 0.79). All the items except 'awakening from sleep' belonged to the OAB-q symptom bother domain.

CONCLUSIONS

It is possible to roughly but sufficiently infer patient perceptions of bladder condition and symptom bother by measuring symptom severity, as estimated by the OABSS.

摘要

目的

通过分别使用膀胱过度活动症症状评分(OABSS)和患者报告的结局测量来评估膀胱过度活动症(OAB)患者的症状严重程度与患者感知之间的关系。

患者和方法

对 OAB 患者的现有数据进行了事后分析。除了 OABSS 之外,患者还完成了三个患者报告的结局测量,即 OAB 问卷(OAB-q)、患者对膀胱状况的感知(PPBC)和医疗结局研究 36 项简短量表(SF-36)。通过与 OAB-q、PPBC 和 SF-36 的相关性来评估 OABSS 的相关性;所有分析均为探索性分析。

结果

共分析了 194 名参与者;OABSS 与 PPBC 和 OAB-q 健康相关生活质量子量表密切相关(r = 0.36-0.57)。与 OAB-q 症状困扰(r = 0.73)的相关性尤其好。然而,OABSS 与 SF-36 子量表的相关性稍低(r = 0.16-0.27)。OABSS 与 OAB-q 项目之间存在相当密切的相关性;日间频率与“日间排尿频率”(r = 0.44);夜间频率与“夜间排尿”(r = 0.44)、“夜间因需要排尿而醒来”(r = 0.51)和“从睡眠中醒来”(r = 0.44);急迫性与“突然有少量或无警告的排尿紧迫感”(r = 0.65)和“无法控制的排尿紧迫感”(r = 0.69),急迫性尿失禁与“少量尿液意外流失”(r = 0.74)和“与强烈排尿欲望相关的尿失禁”(r = 0.79)。除了“从睡眠中醒来”之外,所有项目均属于 OAB-q 症状困扰域。

结论

通过测量 OABSS 估计的症状严重程度,大致但足够地推断出患者对膀胱状况和症状困扰的感知是有可能的。

相似文献

1
Symptom severity and patient perceptions in overactive bladder: how are they related?膀胱过度活动症的症状严重程度和患者感知:它们之间有何关联?
BJU Int. 2009 Oct;104(7):968-72. doi: 10.1111/j.1464-410X.2009.08498.x. Epub 2009 Mar 10.
2
Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.用托特罗定治疗的膀胱过度活动症患者症状改善与膀胱状况、症状困扰及健康相关生活质量的患者评估之间的关系。
Int J Clin Pract. 2008 Jun;62(6):925-31. doi: 10.1111/j.1742-1241.2008.01778.x.
3
Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).四种膀胱过度活动症患者问卷的重测信度:膀胱过度活动症问卷(OAB-q)、患者膀胱状况感知问卷(PPBC)、尿急问卷(UQ)以及原发性膀胱过度活动症症状问卷(POSQ)。
Neurourol Urodyn. 2005;24(3):215-25. doi: 10.1002/nau.20110.
4
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
5
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
6
Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.在接受抗毒蕈碱药物治疗的膀胱过度活动症患者中,膀胱过度活动症症状评分的改善与健康相关生活质量问卷之间的相关性。
Neurourol Urodyn. 2011 Sep;30(7):1309-14. doi: 10.1002/nau.21065. Epub 2011 May 10.
7
Understanding the elements of overactive bladder: questions raised by the EPIC study.了解膀胱过度活动症的要素:EPIC研究提出的问题
BJU Int. 2008 Jun;101(11):1381-7. doi: 10.1111/j.1464-410X.2008.07573.x. Epub 2008 Mar 10.
8
Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.索利那新治疗西班牙裔患者膀胱过度活动症:来自卫喜康开放标签试验的患者报告的症状困扰及生活质量结果
Int J Clin Pract. 2008 Jan;62(1):39-46. doi: 10.1111/j.1742-1241.2007.01644.x. Epub 2007 Nov 23.
9
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
10
The responsiveness of the OAB-q among OAB patient subgroups.膀胱过度活动症患者亚组中膀胱过度活动症问卷(OAB-q)的反应性。
Neurourol Urodyn. 2007;26(2):196-203. doi: 10.1002/nau.20342.

引用本文的文献

1
Relevant markers for overactive bladder laser therapy: nitric oxide and urinary nerve growth factor.膀胱过度活动症激光治疗的相关标志物:一氧化氮和尿神经生长因子。
Lasers Med Sci. 2025 Feb 6;40(1):73. doi: 10.1007/s10103-025-04330-0.
2
Joint Terminology Report: Terminology Standardization for Female Bladder Pain Syndrome.联合术语报告:女性膀胱疼痛综合征的术语标准化
Int Urogynecol J. 2025 Feb;36(2):265-277. doi: 10.1007/s00192-024-05923-z. Epub 2025 Jan 3.
3
Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women.
膀胱过度活动症伴遗尿女性的危险因素、尿动力学特征及相关困扰
Sci Rep. 2025 Jan 2;15(1):235. doi: 10.1038/s41598-024-84031-w.
4
Utilizing Bladder Diaries to Prevent Unnecessary Treatment in Patients With Storage Dysfunction: A Retrospective Study.利用膀胱日记预防储尿功能障碍患者的不必要治疗:一项回顾性研究。
Cureus. 2024 Sep 2;16(9):e68437. doi: 10.7759/cureus.68437. eCollection 2024 Sep.
5
Efficacy and Safety of Combination Therapy With Vaginal and Urethral Erbium-Doped Yttrium-Aluminum-Garnet (Er:YAG) Laser for Overactive Bladder With Urinary Incontinence.阴道和尿道掺铒钇铝石榴石(Er:YAG)激光联合治疗伴尿失禁的膀胱过度活动症的疗效和安全性
Cureus. 2024 Jun 14;16(6):e62363. doi: 10.7759/cureus.62363. eCollection 2024 Jun.
6
Urinary beta 3-adrenoceptor as a diagnostic biomarker for overactive bladder in women.尿β3-肾上腺素能受体作为女性膀胱过度活动症的诊断生物标志物。
Sci Rep. 2023 Nov 8;13(1):19368. doi: 10.1038/s41598-023-46786-6.
7
Overactive Bladder Symptoms Negatively Affect Sleep Quality of Patients With Depression.膀胱过度活动症症状对抑郁症患者的睡眠质量有负面影响。
Int Neurourol J. 2021 Mar;25(1):59-68. doi: 10.5213/inj.2040110.055. Epub 2021 Jan 19.
8
Comprehensive Review of Effective Application of Questionnaires for Clinical Research on Lower Urinary Tract Symptoms With Translation and Cultural Adaptation to the Korean Language.《下尿路症状临床研究问卷有效应用的综合综述:韩语翻译与文化调适》
Int Neurourol J. 2020 Dec;24(4):313-323. doi: 10.5213/inj.2040074.037. Epub 2020 Dec 31.
9
Vibegron improves quality-of-life measures in patients with overactive bladder: Patient-reported outcomes from the EMPOWUR study.维贝格隆改善膀胱过度活动症患者的生活质量:来自 EMPOWUR 研究的患者报告结果。
Int J Clin Pract. 2021 May;75(5):e13937. doi: 10.1111/ijcp.13937. Epub 2021 Jan 22.
10
Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study.米拉贝隆附加疗法治疗膀胱过度活动症男性患者:MATCH 研究的事后疗效分析。
Adv Ther. 2021 Jan;38(1):739-757. doi: 10.1007/s12325-020-01517-5. Epub 2020 Nov 27.